These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 11860301)

  • 1. Molecular testing in the diagnosis and management of hepatitis C virus infection.
    Podzorski RP
    Arch Pathol Lab Med; 2002 Mar; 126(3):285-90. PubMed ID: 11860301
    [TBL] [Abstract][Full Text] [Related]  

  • 2. NIH Consensus Statement on Management of Hepatitis C: 2002.
    NIH Consens State Sci Statements; 2002 Jun 10-12; 19(3):1-46. PubMed ID: 14768714
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular diagnostics of hepatitis C virus infection: a systematic review.
    Scott JD; Gretch DR
    JAMA; 2007 Feb; 297(7):724-32. PubMed ID: 17312292
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Virological tools to diagnose and monitor hepatitis C virus infection.
    Chevaliez S
    Clin Microbiol Infect; 2011 Feb; 17(2):116-21. PubMed ID: 21054664
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of qualitative (COBAS AMPLICOR HCV 2.0 versus VERSANT HCV RNA) and quantitative (COBAS AMPLICOR HCV monitor 2.0 versus VERSANT HCV RNA 3.0) assays for hepatitis C virus (HCV) RNA detection and quantification: impact on diagnosis and treatment of HCV infections.
    Desombere I; Van Vlierberghe H; Couvent S; Clinckspoor F; Leroux-Roels G
    J Clin Microbiol; 2005 Jun; 43(6):2590-7. PubMed ID: 15956369
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Advances in the molecular diagnosis of hepatitis C and their clinical implications.
    Germer JJ; Zein NN
    Mayo Clin Proc; 2001 Sep; 76(9):911-20. PubMed ID: 11560302
    [TBL] [Abstract][Full Text] [Related]  

  • 7. How to use virological tools for optimal management of chronic hepatitis C.
    Chevaliez S; Pawlotsky JM
    Liver Int; 2009 Jan; 29 Suppl 1():9-14. PubMed ID: 19207960
    [TBL] [Abstract][Full Text] [Related]  

  • 8. COBAS ® AmpliPrep/COBAS ® Taqman ® HCV Quantitative Test, version 2.0: an in vitro test for hepatitis C virus RNA quantification.
    Deeks ED
    Mol Diagn Ther; 2015 Feb; 19(1):1-7. PubMed ID: 25351623
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatitis C virus RNA assays: current and emerging technologies and their clinical applications.
    Al Olaby RR; Azzazy HM
    Expert Rev Mol Diagn; 2011 Jan; 11(1):53-64. PubMed ID: 21171921
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatitis C virus diagnostics: technology, clinical applications and impacts.
    Conry-Cantilena C
    Trends Biotechnol; 1997 Feb; 15(2):71-6. PubMed ID: 9081301
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Successful HCV genotyping of previously failed and low viral load specimens using an HCV RNA qualitative assay based on transcription-mediated amplification in conjunction with the line probe assay.
    Comanor L; Elkin C; Leung K; Krajden M; Kronquist K; Nicolas K; Horansky E; deMedina M; Kittichai P; Sablon E; Ziermann R; Sherlock C
    J Clin Virol; 2003 Sep; 28(1):14-26. PubMed ID: 12927747
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of Serologic and Molecular Diagnostic Assays in Identification and Management of Hepatitis C Virus Infection.
    Cloherty G; Talal A; Coller K; Steinhart C; Hackett J; Dawson G; Rockstroh J; Feld J
    J Clin Microbiol; 2016 Feb; 54(2):265-73. PubMed ID: 26659219
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Appendix: The National Institutes of Health Consensus Development Conference Management of Hepatitis C 2002.
    Seeff LB; Hoofnagle JH
    Clin Liver Dis; 2003 Feb; 7(1):261-87. PubMed ID: 12691470
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The diagnosis of hepatitis C virus infection].
    Gervain J
    Orv Hetil; 2014 Jun; 155(26):1019-23. PubMed ID: 24954143
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analytical and clinical sensitivity of the Procleix Ultrio HIV-1/HCV/HBV assay in samples with a low viral load.
    Katsoulidou A; Moschidis Z; Sypsa V; Chini M; Papatheodoridis GV; Tassopoulos NC; Mimidis K; Karafoulidou A; Hatzakis A
    Vox Sang; 2007 Jan; 92(1):8-14. PubMed ID: 17181585
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of the VERSANT HCV RNA qualitative assay (transcription-mediated amplification) and the COBAS AMPLICOR hepatitis C virus test, version 2.0, in patients undergoing interferon-ribavirin therapy.
    Germer JJ; Zein NN; Metwally MA; Hoskin TL; Scott Harmsen W; Smith TF; Patel R
    Diagn Microbiol Infect Dis; 2003 Dec; 47(4):615-8. PubMed ID: 14711484
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Diagnostic strategies in Hepatitis C virus infection].
    Iancu LS
    Rev Med Chir Soc Med Nat Iasi; 2001; 105(1):37-42. PubMed ID: 12092156
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Complete eradication of hepatitis C virus after interferon treatment for chronic hepatitis C.
    De Mitri MS; Morsica G; Chen CH; Mele L; Baccarini P; Chianese R; Piccinini A; Lazzarin A; Pisi E
    Ital J Gastroenterol Hepatol; 1997 Jun; 29(3):255-61. PubMed ID: 9646218
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnosis and monitoring of HCV infection using the cobas
    Yao JD; Young S; Heilek GM; Marino E; Paxinos EE; Marins EG; Valsamakis A
    J Clin Virol; 2018 May; 102():63-69. PubMed ID: 29518694
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Laboratory approaches to the diagnosis of hepatitis C virus infection.
    Jerome KR; Gretch DR
    Minerva Gastroenterol Dietol; 2004 Mar; 50(1):9-20. PubMed ID: 15719002
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.